INCR

InterCure Ltd. (INCR) Risks & Opportunities Analysis (2026)

Invetso Score: 7/10 — Strong · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Risks

Score: 6.1 (Moderate)

Extended cash conversion cycle and 209-day receivables collection can pressure working capital and liquidity versus peers with faster cash turns, limiting flexibility in slower demand periods.

Inventory days near 172 and payables only partially offset that build, so supply-chain or demand normalization could leave INCR more exposed than leaner software peers.

Interest coverage is not meaningful in the provided metrics, and while net debt is negative, peers with stronger cash generation still have more visible cushion against cyclical volatility.

Debt-to-equity remains moderate at 0.46, which is manageable, but it offers less balance-sheet optionality than net-cash peers if growth or collections weaken.

Free cash flow margin is unavailable, so the market may discount visibility versus peers with consistently disclosed cash conversion and stronger proof of earnings quality.

Opportunities

Score:

Net cash position, shown by negative net debt to EBITDA, gives INCR more resilience and strategic flexibility than leveraged peers if demand softens or investment rises.

Current and quick ratios near 1.5 and 1.0 indicate adequate near-term liquidity, supporting execution better than peers that rely on external funding to bridge working-capital swings.

If receivables and inventory normalize, the very high cash conversion cycle can release meaningful cash, creating upside versus peers already operating closer to steady-state efficiency.

Moderate leverage alongside net cash provides room to absorb customer timing volatility better than debt-heavy peers, preserving positioning in a working-capital-intensive model.

Overall Score

Score:

INCR’s net-cash balance sheet and adequate liquidity support peer-relative resilience, but very weak working-capital efficiency and long receivable cycles keep downside meaningful.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on InterCure Ltd.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →